Valuation: Protia Inc.

Market Cap 76.38B 56.9M 50.56M 47.12M 43M 81.04M 5.48B 81.8M 572M 221M 2.79B 214M 209M 9B P/E 2024
14.5x
P/E 2025 18x
Enterprise Value 63B 46.93M 41.7M 38.87M 35.47M 66.84M 4.52B 67.47M 472M 183M 2.3B 176M 172M 7.43B EV / Sales 2024
2.1x
EV / Sales 2025 4.43x
Free-Float
57.15%
Yield 2024 *
-
Yield 2025 -
1 day-1.66%
1 week+10.63%
Current month+1.37%
1 month+13.17%
3 months+49.56%
6 months+32.37%
Current year-4.97%
1 week 5,110
Extreme 5110
6,200
1 month 4,950
Extreme 4950
6,200
Current year 3,680
Extreme 3680
6,240
1 year 3,680
Extreme 3680
6,890
3 years 2,430
Extreme 2430
6,890
5 years 2,430
Extreme 2430
8,440
10 years 2,430
Extreme 2430
17,350
Manager TitleAgeSince
Chief Executive Officer 65 01/06/2010
Corporate Officer/Principal 61 03/06/2022
Sales & Marketing 69 -
Director TitleAgeSince
Director/Board Member 65 01/06/2010
Director/Board Member 68 24/10/2020
Director/Board Member 61 03/06/2022
Change 5-day change 1-year change 3-year change Capi.($)
-1.66%+10.63%+26.84%+71.39% 56.71M
+0.84%-3.74%-27.56%+1.79% 169B
-0.07%-2.55%-11.59%+12.86% 110B
+0.90%+1.13%-25.66%+3.60% 106B
-1.24%-0.76%-49.50%-12.08% 73.87B
-0.24%+0.69%+2.08%+71.44% 58.98B
-0.86%+2.96%+12.91%+61.58% 51.28B
-0.71%-3.82%-8.68%-31.71% 48.16B
+0.12%-0.17%-17.87%+21.91% 40.84B
-1.01%-1.45%+27.31%-6.14% 32.21B
Average -0.39%+0.42%-7.17%+19.46% 69.02B
Weighted average by Cap. +0.03%-1.30%-17.07%+11.23%

Financials

2024 2025
Net sales 10.51B 7.83M 6.96M 6.49M 5.92M 11.16M 754M 11.26M 78.7M 30.49M 384M 29.4M 28.76M 1.24B 15.12B 11.26M 10.01M 9.33M 8.51M 16.04M 1.08B 16.19M 113M 43.85M 553M 42.28M 41.35M 1.78B
Net income 2.44B 1.82M 1.62M 1.51M 1.37M 2.59M 175M 2.62M 18.28M 7.08M 89.3M 6.83M 6.68M 288M 4.47B 3.33M 2.96M 2.76M 2.52M 4.74M 321M 4.79M 33.47M 12.97M 163M 12.5M 12.23M 527M
Net Debt -13.23B -9.86M -8.76M -8.17M -7.45M -14.04M -949M -14.17M -99.06M -38.38M -484M -37M -36.2M -1.56B -13.38B -9.97M -8.86M -8.26M -7.53M -14.2M -960M -14.33M -100M -38.8M -489M -37.41M -36.59M -1.58B
Logo Protia Inc.
Protia Inc is a Korea-based company mainly engaged in the research and development of in vitro diagnostic medical devices and diagnostic reagents. The Company mainly produces allergy diagnostic reagents, allergy diagnostic equipment, point-of-care diagnosis products (POCT), among others. In addition, the Company is engaged in provision of protein related analysis services.
Employees
-
Date Price Change Volume
02/10/26 ₩5,930.00 -1.66% 49,583
01/10/26 ₩6,030.00 +3.08% 77,241
30/09/26 ₩5,850.00 +1.92% 179,205
29/09/26 ₩5,740.00 +8.30% 445,058
  1. Stock Market
  2. Stocks
  3. A303360 Stock